FilingSEC EDGAR8-K
BioRestorative Therapies to Effect 1-for-20 Reverse Stock Split
· SEC accepted
StageEffective
Filing content
The company filed to effect a 1-for-20 reverse stock split effective at 4:30 p.m. ET on September 7, 2026, to maintain Nasdaq listing compliance.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…